The Ashtekar Frontiers of Science Lectures in the Eberly College of Science, a series of free public lectures now in its 32nd year, will return to Penn State on Jan. 24. This year’s lecture series, ...

Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...

WELCOME TO NEW HAMPSHIRE’S BUSINESS. I’M FRED KOCHER. NEW HAMPSHIRE’S VIBRANT AND GROWING LIFE SCIENCES CALLED THE BIOSCIENCE INDUSTRY IS GROWING. NEW HAMPSHIRE’S ECONOMY IN BIG, NEW WAYS. BUT LIKE ...

Scott Barry Kaufman, PhD, is passionate about helping all kinds of people live creative, fulfilling and self-actualized lives. As the keynote speaker at the College of Arts and Sciences’ inaugural Dr.

Orchestra Life Sciences is moving its headquarters from Montreal in Canada, to the Philadelphia Navy Yard as it prepares for rapid growth, writes John George for the Philadelphia Business Journal. The ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every ...

Oct. 20 (UPI) --Anthropic on Monday announced a new service called Claude of Life Sciences that uses artificial intelligence in efforts to advance scientific discovery. This is the San Francisco-based ...

With advanced observatories like the Vera Rubin Telescope coming online, scientists are planning for the discovery of alien intelligence and how humanity should prepare for the news. Professor Dominik ...

The Department of Agricultural Leadership, Education and Communications, part of the Texas A&M College of Agriculture and Life Sciences, has launched its first endowed lecture series: the Meeker ...

The Ohio University Frontiers in Science Lecture Series will feature Dr. Frederic Bertley, president and CEO of COSI (Center of Science and Industry) and CEO of the National Veterans Memorial and ...

Caris Life Sciences stands out for its broad molecular and AI-driven cancer diagnostics but faces upcoming volatility as the IPO lock-up expires on 15 December 2025. CAI's revenue growth is robust, ...